Aromasin 25 mg (30 Tablets) | Exemestane Breast Cancer Treatment | Pfizer
Aromasin 25 mg is a vital prescription medication containing the active ingredient Exemestane. It is a potent, irreversible aromatase inhibitor used in the treatment of hormone receptor-positive (HR+) breast cancer in postmenopausal women. This 30-tablet package from Pfizer is designed to significantly lower estrogen levels as part of a comprehensive cancer treatment plan.
Details
Description
Aromasin 25 mg Exemestane (30 Tablets)
Aromasin 25 mg is a vital prescription medication containing the active ingredient Exemestane. It is a potent, irreversible aromatase inhibitor used in the treatment of hormone receptor-positive (HR+) breast cancer in postmenopausal women. This 30-tablet package from Pfizer is designed to significantly lower estrogen levels as part of a comprehensive cancer treatment plan.
Product Overview: Aromasin 25 mg (Exemestane)
Aromasin 25 mg (Exemestane) is an essential oral therapy in oncology. It is prescribed for postmenopausal women diagnosed with hormone-sensitive breast cancer.
It is commonly used as an “adjuvant” therapy (after 2-3 years of tamoxifen) to help prevent cancer from returning, or as a first- or second-line treatment for advanced (metastatic) breast cancer. Aromasin is a steroidal aromatase inhibitor, which works by deactivating the enzyme responsible for producing estrogen.
How Does Aromasin 25 mg (Exemestane) Work?
The active ingredient, Exemestane, is an irreversible steroidal aromatase inhibitor. In postmenopausal women, the main source of estrogen is the conversion of other hormones (androgens) into estrogen by an enzyme called aromatase.
Aromasin works by permanently binding to and deactivating this aromatase enzyme. This action effectively “shuts down” the body’s estrogen production. Since many breast cancers are “hormone receptor-positive,” they use estrogen as fuel to grow. By drastically reducing estrogen levels, Aromasin helps to “starve” the cancer cells, slowing or stopping their growth.
Key Product Details
| Feature | Detail |
| Brand: | Aromasin |
| Manufacturer: | Pfizer |
| Active Ingredient: | Exemestane |
| Dosage Strength: | 25 mg |
| Form: | Sugar-coated tablet |
| Package Size: | 30 tablets (Approx. 1-month supply) |
| Indication: | Hormone receptor-positive breast cancer (postmenopausal) |
Dosage and Administration
The standard recommended dosage is one 25 mg tablet taken once daily, preferably after a meal.
Important: This is a prescription-only medication and must be taken under the strict supervision of your oncologist or healthcare provider. For best results, take it at the same time each day. Taking it after a meal (especially a meal with some fat) can significantly increase the absorption of the medication.
Frequently Asked Questions (FAQ) about Aromasin 25 mg
What is the difference between Aromasin (Exemestane) and Femera (Letrozole)?
Both are aromatase inhibitors that lower estrogen. The main difference is their chemical structure: Aromasin (Exemestane) is a steroidal and irreversible inhibitor (it permanently deactivates the enzyme). Femera (Letrozole) is non-steroidal and reversible. Your doctor will choose the best one for your specific condition.
How long do I need to take Aromasin 25 mg?
The duration of treatment is determined by your doctor based on your specific stage of cancer and treatment plan. For adjuvant therapy (preventing recurrence), hormonal treatments are often taken for a total of 5 to 10 years.
Is Aromasin used for other types of hormone regulation?
Aromasin’s only approved medical use is for breast cancer. Because it is a powerful anti-estrogen, it has been used “off-label” by male bodybuilders to manage estrogenic side effects. This is not an approved medical use, is not recommended, and carries significant health risks.
What are the common side effects of Aromasin 25 mg?
By lowering estrogen, Aromasin can cause side effects similar to menopause. These often include hot flashes, joint pain (arthralgia), fatigue, headache, and insomnia. A serious potential side effect is the loss of bone mineral density, which can lead to osteoporosis. Your doctor will monitor your bone health.
Important Safety Information
Aromasin (Exemestane) is intended for use only in women who are postmenopausal. It must not be taken by women who are premenopausal, pregnant, or who may become pregnant, as it can cause serious fetal harm.
Before taking Aromasin 25 mg, you must inform your doctor of your complete medical history, including:
- If you are not fully postmenopausal.
- If you have severe liver or kidney problems.
- If you have a history of osteoporosis, osteopenia, or bone fractures (as this drug can weaken bones).
- If you are taking any medications that contain estrogen (such as hormone replacement therapy).
Disclaimer: This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Aromasin (Exemestane) is a potent prescription medication. Always consult with your oncologist or qualified healthcare provider for any health-related questions.

Reviews
Clear filtersThere are no reviews yet.